Taiho Oncology, Inc. | Making the Human Connection

Features

Product Pipeline

Find out about the anti-cancer drugs we have in development

TAIHO ONCOLOGY, INC.

Learn more about our company history and overall mission

CULTURE

Hear first-hand what it is like to work at Taiho Oncology

Press Releases

Taiho Oncology Announces Updated Efficacy and Safety Data for Futibatinib in Cholangiocarcinoma at 2022 ASCO Annual Meeting
Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taiho’s Acquisition of Cullinan Pearl
U.S. Food and Drug Administration (FDA) Accepts for Priority Review Taiho Oncology’s New Drug Application for Futibatinib for Cholangiocarcinoma

See how Taiho is making a difference in our community!

Our Initiatives

Job Postings

Considering a career at Taiho Oncology? Search our Job Board!